MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 14 05 2019
revised: 11 06 2019
accepted: 12 06 2019
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 8 8 2019
Statut: ppublish

Résumé

The identification of novel prognostic biomarkers for melanoma metastasis is essential to improve patient outcomes. To this aim, we characterized miRNA expression profiles in relation to metastasis in melanoma and correlated miRNAs expression with clinical-pathological factors. MiR-145-5p, miR-150-5p, miR-182-5p, miR-203-3p, miR-205-5p and miR-211-5p expression levels were analyzed in primary cutaneous melanomas, including thin and thick melanomas, and in melanoma metastases by quantitative Real-Time PCR. A significantly lower miR-205-5p expression was found in metastases compared to primary melanomas. Furthermore, a progressive down-regulation of miR-205-5p expression was observed from loco-regional to distant metastasis. Significantly lower miR-145-5p and miR-203-3p expression levels were found in cases with Breslow thickness >1 mm, high Clark level, ulceration and mitotic rate ≥1/mm

Sections du résumé

BACKGROUND/AIM OBJECTIVE
The identification of novel prognostic biomarkers for melanoma metastasis is essential to improve patient outcomes. To this aim, we characterized miRNA expression profiles in relation to metastasis in melanoma and correlated miRNAs expression with clinical-pathological factors.
MATERIALS AND METHODS METHODS
MiR-145-5p, miR-150-5p, miR-182-5p, miR-203-3p, miR-205-5p and miR-211-5p expression levels were analyzed in primary cutaneous melanomas, including thin and thick melanomas, and in melanoma metastases by quantitative Real-Time PCR.
RESULTS RESULTS
A significantly lower miR-205-5p expression was found in metastases compared to primary melanomas. Furthermore, a progressive down-regulation of miR-205-5p expression was observed from loco-regional to distant metastasis. Significantly lower miR-145-5p and miR-203-3p expression levels were found in cases with Breslow thickness >1 mm, high Clark level, ulceration and mitotic rate ≥1/mm

Identifiants

pubmed: 31366492
pii: 39/8/4085
doi: 10.21873/anticanres.13566
doi:

Substances chimiques

Biomarkers, Tumor 0
MIRN145 microRNA, human 0
MIRN150 microRNA, human 0
MIRN203 microRNA, human 0
MIRN205 microRNA, human 0
MicroRNAs 0
Mirn182 microRNA, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4085-4093

Informations de copyright

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Virginia Valentini (V)

Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Veronica Zelli (V)

Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Emanuela Gaggiano (E)

Department of Internal Medicine and Medical Specialties, Unit of Dermatology, "Sapienza" University of Rome, Rome, Italy.

Valentina Silvestri (V)

Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Piera Rizzolo (P)

Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Agostino Bucalo (A)

Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Stefano Calvieri (S)

Department of Internal Medicine and Medical Specialties, Unit of Dermatology, "Sapienza" University of Rome, Rome, Italy.

Sara Grassi (S)

Department of Internal Medicine and Medical Specialties, Unit of Dermatology, "Sapienza" University of Rome, Rome, Italy.

Pasquale Frascione (P)

Department of Oncologic and Prevention Dermatology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.

Pietro Donati (P)

Laboratory of Cutaneous Histopathology, San Gallicano Dermatologic Institute, Rome, Italy.

Giuseppe Soda (G)

Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Laura Ottini (L)

Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy laura.ottini@uniroma1.it.

Antonio Giovanni Richetta (AG)

Department of Internal Medicine and Medical Specialties, Unit of Dermatology, "Sapienza" University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH